[The therapeutic effect of nitromint retard on patients with stable angina pectoris].

The antianginal [correction of antidiagnose] efficacy of nitromint retard was studied in 62 middle aged patients with angina pectoris in a 4 week treatment with a 24 h dose of 2.6 mg. Bicycle ergometry [correction of A veloergometria] was conducted before the treatment and at the end of the fourth week. The average number of anginal attacks decreased from 4.0 +/- 1.9 to 1.6 +/- 1.3 during the first week and to 0.0 +/- 0.7 at the end of the 3rd week. The average threshold power increased at the end of the 4th week. Nitromint retard increased considerably the tolerance to physical load and did not increase the consumption of oxygen. The desired effect was achieved in 66.13% of the patients.